06.02.2024 22:23:03 - dpa-AFX: Edwards Lifesciences Corp. Q4 Profit Drops, Inline With Estimates

WASHINGTON (dpa-AFX) - Edwards Lifesciences Corp. (EW) announced a profit
for fourth quarter that decreased from the same period last year in line with
the Street estimates.

The company's bottom line totaled $369.9 million, or $0.61 per share. This
compares with $398.4 million, or $0.65 per share, in last year's fourth quarter.

Excluding items, Edwards Lifesciences Corp. reported adjusted earnings of $390.1
million or $0.64 per share for the period.

Analysts on average had expected the company to earn $0.64 per share, according
to figures compiled by Thomson Reuters. Analysts' estimates typically exclude
special items.

The company's revenue for the quarter rose 13.3% to $1.53 billion from $1.35
billion last year.

Edwards Lifesciences Corp. earnings at a glance (GAAP) :

-Earnings (Q4): $369.9 Mln. vs. $398.4 Mln. last year.
-EPS (Q4): $0.61 vs. $0.65 last year.
-Analyst Estimates: $0.64
-Revenue (Q4): $1.53 Bln vs. $1.35 Bln last year.

-Guidance:
Next quarter EPS guidance: $0.62 - $0.66
Next quarter revenue guidance: $1.53 - $1.61 Bln


Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
EDWARDS LIFESCIENCES 936853 Frankfurt 80,810 31.05.24 08:20:01 +1,250 +1,57% 79,890 80,680 80,810 80,810

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH